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Background: There is a remarkable dearth of literature on less pronounced outcomes in malaria, namely prolonged
hospitalization and intensive care requirement. Limitations on routine clinical applicability of the World Health
Organization’s (WHO) guidelines for determination of severity in malaria does result in underestimation of the true
burden of clinicians’ perceived severity in malaria. This study was conducted to evaluate the clinico-laboratory and
malarial severity features to determine their association with mortality, prolonged hospitalization and requirement
of intensive care outcomes.
Methods: A tertiary care hospital based retrospective study was conducted from the year 2007 to 2011 among
microscopically proven adult malaria patients. Logistic regression analysis was performed to determine the factors
associated with mortality, more than seven days hospitalization, intensive care and other supportive requirements.
Results: Of a total of 922 malaria cases studied, more than seven days of hospitalization was the most frequent
outcome (21.8% (201), 95% CI = 19.1-24.5%) followed by intensive care requirement (8.6% (79), 95% CI = 6.8-10.4%)
and in-hospital mortality (1.2% (11), 95% CI = 0.5-1.9%). Odds of mortality were significantly higher with cerebral
malaria, pulmonary oedema/acute respiratory distress syndrome (PE/ARDS), liver dysfunction, severe anaemia,
renal failure, respiratory distress, metabolic acidosis and leucocytosis. More than seven days hospitalization had
inverse association with mortality. Plasmodium falciparum infection, more than three days of history of fever,
haemoglobinuria, renal failure, shock, leucocytosis, severe thrombocytopaenia and every 10 mmHg fall in systolic
blood pressure were the independent predictors of more than seven days of hospitalization. More than three days of
history of fever, cerebral malaria, PE/ARDS, renal failure, metabolic acidosis, hyperparasitaemia, leucocytosis and severe
thrombocytopaenia were independently associated factors with intensive care requirement.
Conclusions: For routine clinical settings, severity definition for malaria needs to be redefined or modified from the
existing WHO guidelines. Leucocytosis and severe thrombocytopaenia should be identified as severity determinant in
malaria. Patients having more than three days history of fever, leucocytosis, severe thrombocytopaenia and renal failure
are more likely to require either prolonged hospitalization and/or intensive care. PE/ARDS alone in Plasmodium vivax
may result in mortality, whereas multiorgan involvement is common in P. falciparum related mortalities.
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Indeed mortality is the most untoward and unfavourable
outcome of malaria. Nonetheless, often various progres-
sively worsening clinico-pathophysiological events pre-
cede and determine the mortality outcome. The World
Health Organization has recognized many such events
as clinico-laboratory features of disease severity in mal-
aria [1]. Conspicuously, features of malarial severity de-
termines the choice of anti-malarial regimen, prognosis
and other less pronounced outcomes, namely allocation to
intensive care facilities and duration of hospitalization. Be-
sides, these less pronounced malarial outcomes in turn be-
come the surrogate determinants of extent of resource
utilization and survival/death [2]. Since profile of malarial
severity differs extensively among diverse population and
endemicity [3], it might also hold true with the determi-
nants of malarial outcomes. Most of the previous studies
have described only mortality in malaria with respect to
different severity determinants. A few studies [2,4] have
discussed the less pronounced outcomes in Plasmodium
falciparum malaria. There is no report exclusively describ-
ing the less pronounced malarial outcomes together
with mortality in adult malaria, except one study [4],
in which “unfavourable outcome” was defined as com-
posite of mortality, intensive care requirement, or dur-
ation of hospitalization ≥5 days.
Additionally, clinicians often come across patients who
do not fulfill standard severity features of malaria but,
require anti-malarial regimens recommended for severe
cases, supportive lifesaving products, intensive care and/
or prolonged hospitalization. Seemingly, the underlying
determinants of less pronounced unfavourable outcomes in
non-severe malaria remain equivocal. These lacunae in the
existing literatures on malarial severity and outcomesFigure 1 Flow chart of patients’ selection and distribution of study ouwarranted an immediate attention and exploration. Current
study was aimed to evaluate the clinico-laboratory and mal-
arial severity features to determine their association with
mortality, prolonged hospitalization and requirement of in-
tensive care outcomes.
Methods
Study design and patients
This study was conducted from January 2007 to December
2011 by extracting patients’ data from their hospital re-
cords onto manual pro forma followed by electronic data-
base formation and analysis. Patients’ inclusion criteria
were: either gender, ≥18 years, hospitalized with acute
malaria, diagnosed by either quantitative buffy coat test or
Leishman’s stained peripheral blood smears with the pres-
ence of asexual forms of Plasmodium vivax or P. falcip-
arum or both, with or without gametocytes. Patients with
coexistent non-malarial febrile illnesses were excluded. All
patients were managed by the hospital clinicians as per
their clinical judgement and national guidelines.
Ethics statement
Before the study commencement, an approval from the in-
stitutional ethics committee, Kasturba Hospital, Manipal
University, Manipal, Karnataka, India was obtained. Retro-
spective study design rendered patients’ consent irrelevant;
however anonymity of all patients was strictly maintained.
Variables
Independent variables
Malaria severity was defined as per the World Health
Organization’s (WHO) guidelines for the management of
severe falciparum malaria in the year 2012 [1]. An adapta-
tion in clinical jaundice/liver dysfunctions’ definition wastcomes across malaria species.
Table 1 Factors associated with mortality in complicated malaria (N = 226)
Risk factors Risk factors, % (event/226) Mortality per risk factor, %(death/no. of event)
Odds ratio
[95% confidence interval]* P - value*
Species of infection$
Plasmodium vivax 43.8 (99) 2 (2/99) Reference
Plasmodium falciparum 50.9 (115) 6.1 (7/115) 3.14 [0.64 - 15.50] 0.20
Age
Up to 40 years 58 (131) 4.6 (6/131) Reference
Between 41–60 years 35 (79) 6.3 (5/79) 1.41 [0.42 - 4.77] 0.58
More than 60 years 7 (16) 0 0 0.99
Gender
Female 22.6 (51) 3.9 (2/51) Reference
Male 77.4 (175) 5.1 (9/175) 0.75 [0.16 - 3.60] 0.72
Determinants of severity
Cerebral malaria 11.1 (25) 16 (4/25) 5.28 [1.43 - 19.53] 0.01
Spontaneous bleeding 31.4 (71) 7 (5/71) 1.88 [0.55 - 6.38] 0.31
Pulmonary oedema/ARDS 28.3 (64) 10.9 (7/64) 4.85 [1.37 - 17.19] 0.01
Liver dysfunction 20.8 (47) 12.8 (6/47) 5.09 [1.48 - 17.50] 0.01
Severe anaemia 15 (34) 14.7 (5/34) 5.35 [1.53 - 18.65] 0.01
Haemoglobinuria 11.1 (25) 8 (2/25) 1.85 [0.38 - 9.07] 0.45
Renal failure 21.2 (48) 14.6 (7/48) 7.43 [2.08 - 26.57] 0.002
Respiratory distress 17.7 (40) 12.5 (5/40) 4.29 [1.24 - 14.82] 0.02
Metabolic acidosis 5.8 (13) 23.1 (3/13) 7.69 [1.77 - 33.47] 0.01
Hyperparasitaemia 4.4 (10) 10 (1/10) 2.29 [0.26 - 19.87] 0.45
Hypoglycaemia 0.9 (2) 100 (2/2) # #
Shock 4.9 (11) 0 # #
Other abnormal lab parameters
Leucocytosis (≥11,000/mm3) 15 (34) 17.6 (6/34) 9.38 [2.49 - 35.33] 0.001
Leucopaenia (≤4,000/mm3) 11.5 (26) 3.8 (1/26) 0.79 [0.10 - 6.51] 0.83
Severe thrombocytopaenia (≤40,000/mm3) 38.1 (86) 8.1 (7/86) 2.73 [0.77 -9.61] 0.12
Supportive requirements
Inotropes 8 (18) 38.9 (7/18) 32.46 [8.25 - 127.73] <0.001
Blood transfusion 36.7 (83) 7.2 (6/83) 2.15 [0.64 - 7.28] 0.22
Mechanical ventilation 12.4 (28) 32.1 (9/28) 46.42 [9.35 - 230.60] <0.001
Dialysis 10.2 (23) 17.4 (4/23) 5.90 [1.58 - 21.97] 0.01
Intensive care 30.1 (68) 14.7 (10/68) 27.07 [3.39 - 216.15] 0.002
Length of hospital stay
More than 7 days of hospital stay 44.7 (101) 1 (1/101) 0.11 [0.01 - 0.91] 0.04
*Confidence intervals that do not overlap the null value of odds ratio = 1, and P-value <0.05 are shown in bold font.
#Statistics could not be computed.
$Mixed infection was excluded due to insufficient cohort size.
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eous three fold elevation in any serum aminotransferases
from their reference upper limits. Severity determinants
were restricted to cerebral malaria (impaired conscious-
ness, coma or multiple generalized convulsions within
24 hours), liver dysfunction, pulmonary edema (PE) oracute respiratory distress syndrome (ARDS) (radiological),
renal failure (serum creatinine >3 mg/dL), shock (systolic
blood pressure <80 mm Hg), spontaneous bleeding, hyper-
parasitaemia (parasite index >5%, i.e. percentage of para-
sitized erythrocytes on Leishman’s stained peripheral
blood smear), hypoglycaemia (blood sugar <40 mg/dL),
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metabolic acidosis (plasma bicarbonate <15 mmol/L) and
severe anaemia (hemoglobin <7 g/dL). In addition, routine
clinico-laboratory parameters and supportive require-
ments were also included as independent variables. The
severity determinants were the worst parameters during
hospitalization as per the WHO guidelines [1].
Dependent variable
In-hospital mortality, intensive care requirement and
duration of hospitalization were the primary outcomes.
Statistical analysis
Dichotomous variables were summarized as frequency
and proportions by malaria species. Logistic regression
analyses were performed to determine the factors associ-
ated with mortality, more than seven days hospitalization,
intensive care and supportive requirements across malaria
cohort, it’s severe and non-severe subgroups. Variables
which yielded a p-value ≤0.2 in univariate logistic regres-
sion analysis were further analysed through multivariate lo-
gistic regression model by ‘forward-Wald’ method. All tests
of significance were two-sided, with a p-value of <0.05 indi-
cating statistical significance. Data analysis was done using
Statistical Package for the Social Sciences version 15.0
(SPSS, South Asia, Bangalore, India).
Results
Of a total of 922 malaria patients studied, P. vivax was
the largest (63.4%, 95% confidence interval (CI) = 60.3-
66.5%) infecting species followed by P. falciparumFigure 2 Kaplan – Meier plot showing cumulative survival probability(34.4%, 95% CI = 31.3-37.5%) and their mixed infections
(2.2%, 95% CI = 1.3-3.2%), Figure 1. Severe malaria was
noted among 24.5% (226/922) patients, 95% CI = 21.7-
27.3%. Occurrences of various complications and their
combinations in the present study have been reported pre-
viously [5]. Among study outcomes, more than seven days
of hospitalization was most frequent (21.8%, 95% CI =
19.1-24.5%) followed by intensive care requirement
(8.6%, 95% CI = 6.8-10.4%) and in-hospital mortality
(1.2%, 95% CI = 0.5-1.9%), Figure 1.Factors associated with mortality in complicated malaria
Mortality occurred with 2 (2%), 7 (6.1%) and 2 (16.7%)
severe P. vivax, P. falciparum and their mixed infections,
respectively. A binary logistic regression analysis was
performed among severe cohort of 226 patients to deter-
mine the factors associated with mortality (Table 1).
Though, mortality proportion was higher in P. falciparum
than P. vivax it was not significant statistically (P = 0.16).
Of severity determinants, odds of mortality were signifi-
cantly higher with cerebral malaria, PE/ARDS, liver dys-
function, severe anaemia, renal failure, respiratory distress
and metabolic acidosis. Leucocytosis was also found to be
associated with mortality. Among supportive require-
ments, inotropes, mechanical ventilation, dialysis and in-
tensive care were associated with mortality. However,
more than seven days of hospitalization had inverse asso-
ciation with mortality [odds ratio (95% confidence inter-
val), 0.11(0.0-0.91)], as the probability decreased with time
after admission, Figure 2.during hospitalization.
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Duration of hospitalization was dichotomized by more
than seven days of hospital stay. Further, the association
of more than seven days of hospitalization with inde-
pendent clinico-laboratory variables among malaria co-
hort, severe and non-severe subgroups of malaria cohort
was analysed separately. In the malaria cohort, P. falcip-
arum infection, more than three days of history of fever,
haemoglobinuria, renal failure, shock, leucocytosis and
severe thrombocytopaenia were the independent predic-
tors of more than seven days of hospitalization (Table 2).
In severe subgroup, haemoglobinuria [adjusted odds
ratio (95% confidence interval), 3.0 (1.1-8.3)], renal fail-
ure [2.4 (1.1-4.8)] and leucocytosis [2.6 (1.1-6.0)] wereTable 2 Factors associated with more than 7 days of hospital




Plasmodium vivax 12 (70/585) Refe
Plasmodium falciparum 38.3 (121/316) 4.57 [3.2
Age
Up to 40 years 18.4 (115/626) Refe
Between 41–60 years 30.2 (75/248) 1.99 [1.4
More than 60 years 22.9 (11/48) 1.39 [0.6
Gender
Male 20.8 (158/760) 1.37 [0.9
Female 26.5 (43/162) Refe
More than 3 days of fever 25.9 (165/638) 2.62 [1.7
Determinants of severity
Cerebral malaria 60 (15/25) 5.73 [2.5
Spontaneous bleeding 42.3 (30/71) 2.91 [ 1.
Pulmonary oedema/ARDS 43.8 (28/64) 3.08 [1.8
Liver dysfunction 51.1 (24/47) 4.11 [2.2
Severe anaemia 50 (17/34) 3.81 [1.9
Haemoglobinuria 72 (18/25) 10.06 [4.1
Renal failure 62.5 (30/48) 7.26 [ 3.9
Respiratory distress 32.5 (13/40) 1.78 [0.9
Metabolic acidosis 61.5 (8/13) 5.93 [1.9
Hyperparasitaemia 40 (4/10) 2.42 [0.6
Hypoglycaemia 0
Shock 54.5 (6/11) 4.40 [1.3
Other abnormal lab parameters
Leucocytosis (≥11,000/mm3) 53.1 (26/49) 4.59 [2.5
Leucopaenia (≤4,000/mm3) 20.7 (35/169) 0.89 [0.5
Severe thrombocytopaenia
(≤40,000/mm3)
37.3 (76/204) 0.36 [0.2
*Confidence intervals that do not overlap the null value of odds ratio = 1, and P-val
#Statistics could not be computed.
^Patients with mortality outcome were excluded from analysis.
$Mixed infection was excluded due to insufficient cohort size.the independent predictors of more than seven days of
hospitalization. However severe P. falciparum infection
showed significantly higher odds [2.2 (1.3-3.8)] with re-
spect to severe P. vivax for more than seven days hos-
pital stay on univariate logistic regression but, it did not
figure in the multivariate logistic regression analysis.
In non-severe subgroup, P. falciparum infection [7.6
(1.4 – 42.4)] and every 10 mmHg fall in systolic blood
pressure [0.6 (0.3-0.9)] were the independent predictors of
more than seven days of hospitalization.
Factors associated with intensive care support
In malaria cohort, over three days of history of fever, cere-
bral malaria, PE/ARDS, renal failure, metabolic acidosis,stay^ (Malaria cohort = 922)
ratio
nce interval]* P - value*
Adjusted odd ratio
[95% confidence interval]* P - value*
rence Reference
6 - 6.40] <0.001 3.15 [2.16 - 4.60] <0.001
rence
1 - 2.81] <0.001
9 - 2.81] 0.36
3 - 2.03] 0.11
rence
4 - 3.95] <0.001 2.12 [1.33 - 3.39] 0.002
3 - 12.95] <0.001
76 - 4.79] <0.001
3 - 5.18] <0.001
7 - 7.45] <0.001
1 - 7.61] <0.001
4 - 24.45] <0.001 4.69 [1.63 - 13.56] 0.004
1 - 13.46] <0.001 2.20 [1.06 - 4.55] 0.035
0 - 3.51] 0.10
2 - 18.32] 0.002
8 - 8.65] 0.18
# # # #
3 - 14.57] 0.02 4.88 [1.17 - 20.42] 0.03
4 - 8.30] <0.001 2.29 [1.13 - 4.64] 0.02
9 - 1.34] 0.57
5 - 0.51] <0.001 1.93 [1.29 - 2.88] 0.001
ue <0.05 are shown in bold font.
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cytopaenia were independently associated with inten-
sive care (Table 3). In severe subgroup, >3 days of
history of fever [5.4 (1.3-21.9)], PE/ARDS [3.3 (1.5-
7.3)], metabolic acidosis [12.3 (1.8-82.8)], leucocytosis
[5.1 (2.0-13)] and severe thrombocytopaenia [3.5 (1.6-
7.5)] were the independent predictors of intensive care.
P. falciparum was more likely to result in intensive
care need in both the malaria cohort [4.0 (2.41-6.62)]
and the severe malaria subgroup [2.1 (1.1-3.8)] in uni-
variate logistic regression analysis. Intensive care
support was needed among substantially less propor-
tion i.e. 1.6% (11/696) of non-severe subgroup.Table 3 Factors associated with intensive care support^ (Mala




Plasmodium vivax 4.3 (25/585) Refer
Plasmodium falciparum 15.1 (48/317) 4.00 [2.4
Age
Up to 40 years 6.2 (39/626) Refer
Between 41–60 years 12.9 (32/248) 2.23 [1.3
More than 60 years 16.7 (8/48) 3.01 [1.3
Gender
Male 7.8 (59/760) 1.67 [0.98
Female 12.3 (20/162) Refer
More than 3 days of fever 11.1 (71/638) 5.55 [2.38
Determinants of severity
Cerebral malaria 64 (16/25) 25.53 [10.0
Spontaneous bleeding 36.6 (26/71) 8.70 [4.98
Pulmonary oedema/ARDS 46.9 (30/64) 14.57 [8.2
Liver dysfunction 40.4 (19/47) 9.22 [4.87
Severe anaemia 29.4 (10/34) 4.93 [2.27
Haemoglobinuria 52 (13/25) 13.83 [6.0
Renal failure 47.9 (23/48) 13.44 [7.1
Respiratory distress 32.5 (13/40) 5.95 [2.93
Metabolic acidosis 76.9 (10/13) 40.58 [10.9
Hyperparasitaemia 40 (4/10) 7.44 [2.05
Hypoglycaemia 50 (1/2) 10.42 [0.65
Shock 36.4 (4/11) 6.37 [1.82
Other abnormal lab parameters
Leucocytosis (≥11,000/mm3) 46.9 (23/49) 13.92 [7.4
Leucopaenia (≤4,000/mm3) 2.4 (4/169) 0.23 [0.0
Severe thrombocytopaenia
(≤40,000/mm3)
23.5 (48/204) 7.33 [4.43
*Confidence intervals that do not overlap the null value of odds ratio = 1, and P-val
#Statistics could not be computed.
^Patients with mortality outcome were excluded from analysis.
$Mixed infection was excluded due to insufficient cohort size.Association of >7 days of hospitalization, intensive care
and malaria species with supportive requirements
On univariate logistic regression analysis, patients with
over seven days of hospitalization had significantly higher
likelihood of blood transfusion [9.96 (6.46 - 15.34)], mech-
anical ventilation [5.10 (2.37 - 10.96)] and dialysis [11
(4.28 - 28.28)] in malaria cohort. Likewise, patients with
intensive care support were significantly more prone to
have inotrope [15.13 (5.78 - 39.57)], blood transfusion
[16.15 (9.68 - 26.94)], mechanical ventilation [129.48
(37.89 - 442.42)] and dialysis requirements [24.46 (10.00 -
59.87)]. On inter-species comparison, P. falciparum
showed significantly higher odds for inotrope [4.17 (1.44-ria cohort = 922)
ratio
ce interval]* P – value*
Adjusted odds ratio
[95% confidence interval]* P – value*
ence
1 - 6.62] <0.001
ence
6 - 3.65] 0.001
2 - 6.87] 0.01
- 2.87] 0.06
ence
- 12.94] <0.001 5.87 [1.56 - 22.10] 0.01
0 - 55.39] <0.001 12.79 [2.94 - 55.71] 0.001
- 15.19] <0.001
4 - 25.74] <0.001 9.44 [4.07 - 21.88] <0.001
- 17.46] <0.001
- 10.74] <0.001
7 - 31.54] <0.001
7 - 25.17] <0.001 4.70 [1.74 - 12.69] 0.002
- 12.08] <0.001 5.50 [1.70 - 17.85] 0.005
1 - 150.90] <0.001 10.00 [1.26 - 79.57] 0.03
- 26.95] 0.002 5.69 [1.05 - 30.74] 0.04
- 168.44] 0.10 # #
- 22.25] 0.004
1 - 26.16] <0.001 4.17 [1.54 - 11.24] 0.005
8 - 0.63] 0.004 0.26 [0.07 - 1.00] 0.05
- 12.12] <0.001 5.70 [2.77 - 11.73] <0.001
ue <0.05 are shown in bold font.
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http://www.malariajournal.com/content/13/1/37012.11)], blood transfusion [4.94 (3.20-7.61)], mechanical
ventilation [3.40 (1.48-7.78)] and dialysis [17.55 (4.05-
76.13)] than P. vivax (Figure 3).
Discussion
Global health care diligence intends to avert malaria exclu-
sively. However, its untoward occurrences and aggrava-
tions invariably results in extensive resource utilization to
try reverting the ailment. Aftermaths of malaria, namely
prolonged hospitalization, intensive care requirements and
most unfortunate ‘mortality’, are the sheer reflection of
underlying disease severity and extensive resource utiliza-
tions. Here, few determinants of these unpleasant out-
comes in adult malaria at a tertiary care setting have been
identified. Considering clinico-pathophysiological parame-
ters as the independent determinants of the disease sever-
ity and the outcomes, those were analysed across malaria
cohort, severe and non-severe subgroups of total cohort.
Logistic regression analysis revealed significant associ-
ation with mortality of few typical and critical complica-
tions in severe malaria. Noticeably, occurrences of these
complications often results in intensive care requirements
comprising management with inotropes, mechanical ven-
tilation, dialysis requirements, blood transfusion etc. With
mortality outcome, association of cerebral malaria [6-9],
PE/ARDS [6,8,9], liver dysfunction [9,10], severe anaemia
[7,10], renal failure [6,8,10], respiratory distress [7,8,10],
metabolic acidosis [9,10] and leucocytosis [11] have been
reported in various other series as well. Occurrence of
leucocytosis is inconsistent in all forms of malaria and de-
pends on factors, such as severity of disease, parasitaemia,
host immunity and concomitant infections [12]. How-
ever, none of the study patients were having bacter-
aemia or concurrent infections, as this was an exclusion
criterion of this study. Thus, either bacteraemia or con-
current infection as a cause of leucocytosis is overruled.
Furthermore, no history of malaria in cases of mortality
except one (see Additional file 1) suggests non-immune
status and vigorous inflammatory response resulting inFigure 3 Association of more than 7 days of hospitalization, intensive c
*p <0.05.baseline leucocytosis [13]. However, specific immunologic
factors and their association with disease severity/out-
comes in apparently non-immune versus immune malaria
patients with either patent or multiple/recurrent infections
needs to be determined through a prospective approach.
Of severity features leading to mortality, both the P. vivax
infected mortality was due to PE/ARDS and respiratory
distress only, whereas other mortalities were due to multi-
organ complications (Additional file 1).
Consistently across the groups, P. falciparum infection
itself was found to be the independent predictor of more
than seven days hospitalization. This appears to be due to
higher severity proportion of P. falciparum than P. vivax.
Further, more than three days of history of fever gives an
inference of delayed presentation/diagnosis/onset of treat-
ment, which would increase the probability of developing
complications [14], thereby prolonged hospital stay and/or
intensive care requirement/s. Hemoglobinuria, renal fail-
ure and shock are few of the pre-determined and recog-
nized severity determinants by the WHO [1], thus
prolonged hospitalization in their occurrence appears to
be an obvious outcome. Leucocytosis and severe thrombo-
cytopaenia showing an independent association with more
than seven days of hospitalization, intensive care require-
ment and mortality appears to be a reliable and cost effect-
ive laboratory measure, which qualifies to be identified as a
standard and uniform determinant of severity in malaria.
However, further exploration to validate the significance of
leucocytosis and thrombocytopaenia in well planned large
cohort is certainly warranted in other settings and regions.
Thrombocytopaenia having strong association with pro-
longed duration of hospitalization, increased intensive care
requirement and increased mortality has also been reported
previously [4]. Both the less pronounced outcomes of this
study have been observed in substantial proportions among
non-severe malaria cohort as well (Figure 1).
A proportion of non-severe subgroup staying longer
than seven days in hospital is actually a reflection of the
course of artesunate based combination treatment givenare requirement and malaria species with supportive requirements.
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to be a result of physicians’ perceived severe malaria
diagnosis and intensive management in view of either
thrombocytopaenia or mild hypotension or other perni-
cious features not fulfilling the standard severity criteria.
This is being emphasized here that, for routine clinical
practice, strict adoption of WHO defined severity cri-
teria seems inadequate due to its inherent research ori-
ented limitations [3,4].
Noticeably, insignificant mortality observed in present
cohort can be explained in the light of substantially high
proportion of patients, even “non-severe” malaria patients
getting either intensive care or other supportive require-
ments, or prolonged hospitalization. Thus, it has been
substantiated that, by clinical practice oriented severity
definitions and intensive management worse outcomes in
malaria can be minimized in routine clinical settings.
Therefore, either revision of existing WHO severity guide-
lines or development of new severity guidelines exclusively
for clinical practice is required.
Perhaps, this is the first exclusive study describing out-
comes of malaria in adults. Sufficiently large cohort and
robust statistical analysis imparts significant strength to
the study findings. Furthermore, stratified evaluation of
factors for their association with outcomes across mal-
aria cohort, severe and non-severe subgroups confers
additional visibility. Retrospective approach imposes cer-
tain limitations to this study. Data on concurrent non-
febrile comorbidities were not captured for this study,
thus their additive effects on the study outcomes could
not be deduced. Malaria diagnosis and speciation was
solely based on microscopy and lacked molecular con-
firmation. Substantially lesser mortality events restricted
a legitimate multivariate logistic regression analysis.
Thus, future studies on malarial outcomes must com-
prise sufficient subjects each with and without the study
outcomes to determine more robust association. Import-
antly, a multicentric study approach would be greatly
useful to assess and determine the extent of subjectivity
associated with criteria for hospitalization and intensive
unit care across hospitals within different regions.
Conclusions
For routine clinical settings, severity definition for
malaria needs to be redefined or modified from the
existing WHO guidelines. Leucocytosis and severe
thrombocytopenia should be identified as severity de-
terminant in malaria and validated through prospective
approach to determine a reliable intercept. Further,
this study affirms P. falciparum infection to be an in-
dependent predictor of prolonged hospitalization. Pa-
tients having more than three days history of fever,
leucocytosis, severe thrombocytopaenia and renal failure
are more likely to require either prolonged hospitalizationand/or intensive care. Additionally, haemoglobinuria
and shock are the independent predictors of prolonged
hospitalization, whereas, cerebral malaria, PE/ARDS, re-
spiratory distress, metabolic acidosis and hyperparasi-
taemia are the independent predictors of intensive care
requirement in malaria. PE/ARDS alone in P. vivax may
result in mortality, whereas multiorgan involvement is
common in P. falciparum related mortalities.
Additional file
Additional file 1: Profile of patients with mortality outcome.
The clinico-laboratory data of all patients with mortality outcome
have been depicted.
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